Amir Nashat, Director at FATE THERAPEUTICS INC (FATE), sold 38,098 shares at $16.28 ($620K) on 2019-01-18, disclosed to the SEC on 2019-01-23.
Open-market sale of $620k FATE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SRRK | BUY | 2022-06-24 | $6.2M | — | Filing → |
| MORF | SELL | 2021-05-25 | $20.4M | — | Filing → |
| MTCR | BUY | 2020-09-22 | $3.0M | — | Filing → |